Cryosite (CTE.AX) Akcija Цена
Cryosite Цена
U poslednjih 19 godina prihod Cryosite rastao je 6,9 % godišnje i dostigao 16,70 М AUD. Zarada po akciji rasla je 4,1 % godišnje u poslednjih 19 godina. Za Cryosite neto marža od 13,4 % je porasla u odnosu na 11,6 % pre nekoliko godina. Po današnjoj ceni dividendni prinos iznosi otprilike 1,64 %. Odnos isplate je oko 91 % dobiti. Dividenda je rasla 5,5 % godišnje u poslednjih 13 godina.
Cena akcije Cryosite
Pristupite ovim podacima preko Eulerpool API-ja
100.000 zahteva/mes. besplatno · bez kartice
Cryosite poslovni model i analiza akcije
Često postavljana pitanja o akciji Cryosite
The business model of Cryosite Ltd focuses on providing biobanking and cell therapy services. Cryosite specializes in the collection, storage, and distribution of human biological samples such as cord blood, tissue, and cells for medical and research purposes. The company allows individuals and families to preserve cord blood stem cells for potential future use in regenerative medicine. Cryosite also offers cell therapy manufacturing services to support personalized medicine and clinical trials. With its expertise and advanced technology, Cryosite aims to contribute to advancements in medical treatments and research, offering peace of mind to those seeking to preserve their biological materials.
Cryosite Ltd is primarily active in the biomedical and life sciences industries.
The main competitors of Cryosite Ltd in the market are companies like Stemlife, Singapore Cord Blood Bank, and CordLife Group Limited.
Cryosite Ltd, a reputable Australian company, has an intriguing history and background. Established in 2000, Cryosite has played a pivotal role in the field of biomedical services. The company specializes in secure storage and transportation of precious biological samples, supporting medical research, clinical trials, and stem cell transplant programs. With state-of-the-art facilities and stringent quality control measures, Cryosite has gained recognition as a trusted partner for numerous healthcare institutions and research organizations globally. Over the years, Cryosite Ltd has showcased its expertise in preserving and managing these life-changing resources, contributing significantly to advancements in healthcare and cutting-edge research.
Cryosite Ltd has achieved several significant milestones. Firstly, the company successfully established itself as a leading provider of comprehensive storage solutions for stem cells, reproductive tissues, and cord blood in Australia. Additionally, Cryosite Ltd expanded its services by offering advanced cryopreservation techniques, ensuring the long-term viability of stored materials. The company's commitment to quality led to accreditation by the Therapeutic Goods Administration (TGA) and attainment of ISO 9001 certification. Furthermore, Cryosite Ltd expanded its client base, attracting partnerships with major healthcare institutions and research organizations. These milestones demonstrate Cryosite Ltd's success in delivering trusted and state-of-the-art cryogenic storage services to its clients.
Cryosite Ltd primarily operates in Australia and New Zealand.
Cryosite Ltd is a leading company that values integrity, reliability, and innovation. With a strong corporate philosophy focused on providing premium services and solutions in the field of biobanking and reproductive services, Cryosite is committed to excellence. The company strives to ensure the utmost trust and transparency in all its operations, delivering high-quality cryopreservation services, cord blood banking, and stem cell research facilities. Cryosite Ltd continuously pushes boundaries through cutting-edge technology and strategic partnerships, aiming to meet the evolving needs of its customers and make a positive impact in the healthcare industry.
Po trenutnom kursu akcija Cryosite kotira 0,76 EUR (1,22 AUD).
Akcija Cryosite (CTE.AX) kotira na 1 berze, uključujući: ASX (CTE.AX).
Cryosite Ltd is an Australian company that has been operating in the field of biological material storage for over 15 years. With a wide range of services and products, the company has established itself as a leading provider of cryo-storage solutions in Australia.
prihod od Cryosite je 16,70 М AUD. Ova cifra je zasnovana na trenutnim finansijskim podacima i odražava poslovne rezultate preduzeća.
dobit od Cryosite je 2,24 М AUD. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.
Odnos cene i zarade (KGV) za Cryosite je trenutno 28,49. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Cryosite.
Odnos cene i prihoda (KUV) za Cryosite je trenutno 3,81. KUV poredi tržišnu kapitalizaciju sa godišnjim prihodima i služi kao metrika valuacije za akciju Cryosite.
Eulpool score kvaliteta za Cryosite je 7/10.
ISIN za Cryosite je AU000000CTE1. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.
WKN za Cryosite je 621943. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.
Ticker za Cryosite je CTE.AX. Simbol tikera se koristi za trgovinu akcijama Cryosite na berzanskom tržištu.
Cryosite акција
Cryosite Peer grupa
Cryosite Тикер
Cryosite FIGI
Sve ključne metrke i detaljne analize Cryosite u dubinskoj analizi
Naša analiza akcija za akciju Cryosite uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Cryosite. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: